Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Bronchogen and BAC Water Mix

Bronchogen Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Bronchogen Titration Schedule

ItemDetails
Standard dose0.5–2 mg once daily
Courses10–20 days, 2–3× per year
Originator dose10–1000× lower (Russian tradition)

All evidence is one research group's rat COPD model; community protocols diverge (500 mcg ×40 days vs 1 mg 6-on/1-off). The '1–5 mg per dose' figure is a recurring placeholder that never matched a validated protocol for any bioregulator; sources disagree up to 1000× on real doses.

Possible vial strengths:

What Is It?

Bronchogen

Bronchial peptide bioregulator.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Bronchogen

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Bronchogen Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Bronchogen is a Khavinson "bioregulator" — a synthetic tetrapeptide (Ala-Glu-Asp-Leu, AEDL) developed in Russia to target bronchial and deeper lung tissue at the gene level. Unusually, lab work shows it increases the thermal stability of DNA in bronchial cells, suggesting it binds and steadies the double helix while switching on tissue-maintenance genes. It's sold as an oral/sublingual capsule and as a research-grade injectable powder.
Bronchogen (AEDL, a tetrapeptide) drives epithelial-differentiation and surfactant/mucin genes (NKX2-1, FOXA1/2, MUC5AC, SFTPA1), acting on the airway lining and alveolar type-II cells. Chonluten (EDG, a tripeptide) works instead on stress-response and antioxidant genes in the bronchial mucosa. They cover different layers of the respiratory tract, which is why Russian COPD protocols run them together rather than treating one as a substitute for the other.
In a mouse COPD model, Bronchogen reduced hallmark damage — excess mucus-producing (goblet) cells, abnormal epithelial change, and emphysema-type loss of elasticity — while raising secretory IgA, a marker of a restored mucosal immune barrier. Khavinson's group has also floated it (with Chonluten) for virus-related lung injury. All of this is preclinical, largely Russian research, so it is not a proven therapy for asthma, COPD, or any lung condition.
Only the injectable research powder is reconstituted — the oral or sublingual capsule is taken directly. For a 20 mg vial, adding 2.5 mL of bacteriostatic water gives 8 mg/mL, so an 800 mcg amount draws to 0.1 mL (10 units on a U-100 syringe); use more water if you prefer a lower concentration. Respiratory bioregulator courses are pulsed and short, and no injectable human dose is formally established, so any figure here is a research choice, not a recommendation.
Bronchogen has no FDA approval and isn't a medicine in Western markets — it's a research compound or Russian-market supplement, and its safety record comes only from Khavinson-affiliated work, with no double-blind human efficacy data in English. Note that it clears the bloodstream quickly even though its gene effects are said to last, and that respiratory disease is risky to self-treat — proper pulmonary care comes first. Storage: keep the lyophilized powder cold, dry, and out of light; once reconstituted, refrigerate it and use it within a few days.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides